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Targeting oxytocin receptor
(Oxtr)‑expressing neurons
in the lateral septum to restore
social novelty in autism spectrum
disorder mouse models
Machi Horiai1,10, Ayano Otsuka2,10, Shizu Hidema1,2,3, Yuichi Hiraoka4, Ryotaro Hayashi1,5,
Shinji Miyazaki1, Tamio Furuse6, Hiroaki Mizukami7, Ryoichi Teruyama 8, Masaru Tamura6,
Haruhiko Bito 9, Yuko Maejima3, Kenju Shimomura3 & Katsuhiko Nishimori1,2,3*
Autism spectrum disorder (ASD) is a continuum of neurodevelopmental disorders and needs new
therapeutic approaches. Recently, oxytocin (OXT) showed potential as the first anti-ASD drug. Many
reports have described the efficacy of intranasal OXT therapy to improve the core symptoms of
patients with ASD; however, the underlying neurobiological mechanism remains unknown. The OXT/
oxytocin receptor (OXTR) system, through the lateral septum (LS), contributes to social behavior,
which is disrupted in ASD. Therefore, we selectively express hM3Dq in OXTR-expressing (OXTR+)
neurons in the LS to investigate this effect in ASD mouse models developed by environmental and
genetic cues. In mice that received valproic acid (environmental cue), we demonstrated successful
recovery of impaired social memory with three-chamber test after OXTR+ neuron activation in the
LS. Application of a similar strategy to Nl3R451C knock-in mice (genetic cue) also caused successful
recovery of impaired social memory in single field test. OXTR+ neurons in the LS, which are activated
by social stimuli, are projected to the CA1 region of the hippocampus. This study identified a candidate
mechanism for improving core symptoms of ASD by artificial activation of DREADDs, as a simulation
of OXT administration to activate OXTR+ neurons in the LS.
Autism spectrum disorder (ASD) is a heritable neurodevelopmental disorder associated with a combination of
heterogeneous genetic variations; however, environmental cues have also been suspected to be associated with
ASD. The core symptoms of ASD are social deficits, communication difficulties, and repetitive and stereotyped
behaviors1. Although ASD is estimated to affect approximately 1% of children globally2, an effective therapy for
ASD remains to be developed. Mouse models of ASD are based either on the administration of chemical agents
or on editing the genomic DNA sequence of candidate genes suspected to cause ASD. Both these methods
typically result in mice with abnormal behaviors, resembling those observed in patients with ASD. Presently,
such animal models are being utilized in the study of the pathophysiological mechanisms of ASD and in the
development of novel therapeutic tools and strategies for the treatment of ASD. In utero valproic acid (sodium
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valproate; VPA) exposure is widely used to induce an animal model of ASD. VPA is a known therapeutic agent
to treat psychiatric disorders such as bipolar disorder and e pilepsy3; however, a higher prevalence of ASD has
been observed in children born from mothers who were exposed to VPA during p
 regnancy4–7. Similarly, mice
or rats foetuses exposed to VPA had a decrease in the number of Purkinje cells in the intermediate zone of the
cerebellum8, as well as exhibited repetitive behavior and impaired social b
 ehaviors9. These observations suggest
that VPA-induced rodent models of ASD may be helpful to study the relationship between impaired behaviors
and neuronal pathology associated with ASD. However, several ASD mouse models harbour gene mutations
suspected to cause ASD, such as neuroligin3 (R451C) knock-in (Nl3R451C) mice. The Nl3R451C mouse model with
a mutation of Nl310 is one of representative gene-modified ASD mouse models. An X-linked point mutation
leading to an arginine to cysteine substitution at amino acid 451 (R451C) of NL3 (NL3R451C) has been identified
in a subset of human patients with A
 SD11. NL3 is a postsynaptic cell-adhesion molecule that acts as a ligand for
neurexins and regulates s ynaptogenesis12. Knock-in mice expressing the Nl3R451C imitated NL3R451C point
mutation and showed impaired social interaction and excitatory/inhibitory (E/I) imbalance10. Several single
nucleotide polymorphisms in the oxytocin receptor (Oxtr) gene have been reported that are linked to impairment of socio-cognitive f unction13, and Oxtr is considered to be an ASD-causative gene. OXTR is a G-protein
coupled receptor (GPCR) with seven transmembrane domains. In the rodent brain, expression of OXTR is
found in the olfactory pathway, olfactory bulb, and accessory olfactory nucleus, and as a processing pathway
for social information, the medial amygdala, central amygdala, bed nucleus of stria terminalis, piriform cortex,
lateral septum (LS), hippocampus, nucleus accumbens, and prefrontal cortex. In the primate, OXTR expression
is detected in the visual processing area, superior colliculus, superficial gray layer of the superior colliculus,
pulvinar, and primary visual cortex. In addition, OXTR expression is found in the cholinergic region including
the nucleus basalis of Meynert and pedunculopontine tegmental nucleus, which are known to regulate selective
attention and motivation14. Oxytocin (OXT) is one of two neurohypophysial nonapeptide hormones synthesized
in the paraventricular nucleus (PVN) and supraoptic nucleus and binds to the OXTR to induce the activation of
Gq/11, thus eliciting various cellular responses. Such neural excitation in specific regions following the activation of specific neural circuits has been suggested to control sociosexual behaviors, such as pair bonding, social
memory, and prosocial behaviors. These behavioral controls are mediated via complex neural circuits, including
the neurons expressing OXT or OXTR.
Recent studies have demonstrated that the impaired behaviors observed in patients with ASD and animal
models of ASD were recovered to some extent by intranasal administration of OXT; therefore, OXT is now suggested to become an approved therapeutic drug for the treatment of ASD. In view of this evidence, clinical trials
to evaluate the effect of OXT on patients with ASD15–17 and basic research to assess the effect of OXT in animal
models of ASD are now being c onducted18–20. Previous studies have reported that intranasal administration or
intraperitoneal injection of OXT in animal models of ASD resulted in improvements in social memory and other
symptoms of ASD15–17. It was reported that the central OXT system is impaired in VPA rats. OXT expressing
cells and mRNA level were lower in the hypothalamus of VPA rats compared to control rats. Additionally, single
intranasal administration of OXT improved the impaired social behavior of adolescent VPA rats. It was also
shown that after early neonatal OXT manipulation, the number of OXT-expressing cells was significantly restored
in the PVN of VPA rats, and there was a long-term therapeutic effect on autistic-like behavior21.
These studies strongly suggest that OXT administration has significant potential in the treatment of ASD.
However, the causative gene mutations or environmental factors, other than Oxt or Oxtr gene mutations, neural mechanism of ASD, and therapeutic mechanism underlying OXT-induced improvement of social deficits
in these ASD models remain largely unknown. We have previously reported that the LS is an important brain
region in the regulation of social m
 emory22, and speculated that OXT might contribute to the amelioration of
ASD-like behaviors via the LS.
In a psychological study of human, Chen et al. reported the close relation between human social behavior and
neural activation after intranasal administration of OXT, in lateral septal nucleus, where the level of Oxtr gene
expression was suspected to be affected by its DNA methylation level23. However, so far there’s no literature with
description that the OXTR expressed in lateral septal nucleus in human brain closely relates to the therapeutic
mechanism by OXT, intranasally administrated to ASD patients.
OXTR belongs to class 1 family of GPCRs, and it is coupled with trimeric G proteins, whose α subunit is
Gαq/11. Stimulation by binding of OXT, the natural ligand to this receptor, facilitates signal exertion by activation of Phospholipase C, followed by increase of intercellular Ca2+, activation of Protein kinase C, and multiple
cellular reactions. Designer receptors exclusively activated by a designer drug (DREADD) are family of engineered G protein-coupled receptors derived from the human mAChR, which can control three major GPCR
signaling pathways (Gαq/11, Gαi, and Gαs)- depending on specific mutations in their structures. DREADD
subtype 3 (hM3Dq), which is coupled with Gαq, exerts signals and induces firing of neurons after binding of
clozapine N-oxide (CNO) in vitro24 and in vivo25. It was reported that the effect of CNO was observed 30 min
after its administration and continued for up to 120 min25–27. Researchers generally believe that major signal
pathways of hM3Dq can imitate those of many Gαq type G protein-coupled receptors. In this study, we aimed
to investigate the underlying mechanism of the effect of OXTR activation on autistic symptoms in ASD mouse
models developed by environmental and genetic cues.

Results

Activation of OXTR‑expressing neurons in the LS ameliorated the abnormal social novelty
and anxiety observed in VPA mice. To examine whether the LS was involved in social novelty, we first

observed c-Fos protein expression in the LS of Oxtr-Venus (Oxtrvenus/+) mice when they were socially or nonsocially stimulated. Oxtr-Venus mice specifically express the Venus protein in OXTR expressing (OXTR+) neu-
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rons. We observed high expression of c-Fos in the socially stimulated condition (Fig. 1A). Based on previous
findings22,28, we expected that the activation of OXTR+ neurons in the LS and in the neural circuits composed
of such neurons, with the administration of OXT might compensate for the impaired OXTR signalling in VPA
mice and ameliorate their ASD-like symptoms. We treated pregnant Oxtr-Cre (Oxtrcre/+) mice (which specifically express the Cre protein in only the OXTR+ neurons)29 with VPA to generate animal models of ASD (VPA
mice). We then applied the DREADDs artificial receptor system24 to generate a mouse model with restricted
activation of neurons in the LS and neuron subtype (OXTR+)-specific manner to enhance OXTR signalling. To
conduct the “signal enhancement” experiment, we first confirmed that the VPA mice exhibited autism symptoms after VPA (600 mg/kg) was administered intraperitoneally to their mothers on E12.5. The pups exhibited
autism symptoms, indicated by significant reduction in the number of ultrasonic vocalizations, as demonstrated
previously (Fig. 1B)30,31. To generate a signal similar to that of OXTR (when activated by OXT), we used the
artificial receptor, hM3Dq, which is a Gq/11-coupled receptor, in the DREADDs experiment (Fig. 1C). We
injected an Adeno-associated virus (AAV)-DIO-hM3Dq-mCherry vector (hM3Dq vector) into the LS of OxtrCre mice (healthy controls), checked for sufficient transfection by the AAV vector, and confirmed activation
of the infected neurons by administering CNO to the AAV-transfected mice (Fig. 1D). Similarly, an hM3Dq
vector was injected into the LS of VPA mice; subsequently, the operated mice were characterized according to
social novelty (using the three-chamber test), anxiety (using the open-field test), and repetitive behaviors (using
the marble burying test), which are considered related to dysfunction in human ASD (Fig. 1E). Saline-treated
VPA mice showed abnormal social novelty, whereas CNO treatment of VPA mice transfected with the hM3Dq
vector resulted in dramatic improvement in preference for social novelty (Fig. 1F). VPA mice showed normal
sociability (Supplemental Figure S1). We subsequently performed behavioral tests for anxiety, followed by tests
for repetitive behavior. Although abnormal repetitive behavior was not observed in the open field test (Fig. 1I),
contrary to previous reports32, we detected high anxiety in the VPA mice, which was ameliorated after activation
of OXTR+ neurons (Fig. 1B). Importantly, we observed no change in total locomotor activity (Fig. 1G).

Activation of OXTR‑expressing neurons in the LS ameliorated abnormal social novelty in
Nl3R451C mice. Our “signal enhancement” experiment for OXTR+ neurons in the LS of VPA mice implied

that the LS might be an important target for OXT-mediated therapeutic effects in ASD mice. We next examined
whether the same strategy would be effective in a genetic mouse model of ASD, Nl3R451C mice, generated by
mutation of the Nl3 gene. We tested the social novelty of the Nl3R451C: Oxtr-Cre (Nl3:OxtrCre/+) mice using the
three-chamber test and found no abnormal social novelty (Fig. 2A). Abnormal sociability was also not found in
Nl3:OxtrCre/+ mice (Supplemental Figure S2). Furthermore, we tested locomotion and assessed repetitive behavior in these mice, using the open field test and marble burying test respectively. Both behaviors were normal
relative to those of the wild-type mice (Fig. 2B,C). We next examined social novelty using the “social discrimination test,” wherein a “single field” was utilized instead of three-chambers33 (Fig. 2F). We detected impaired
preference for social novelty in Nl3:OxtrCre/+ mice; this impairment was ameliorated by the administration of
CNO in AAV vector-transfected mice (Fig. 2F). Nl3:OxtrCre/+ mice showed normal sociability in the single field
test (Supplemental Figure S2).

OXTR‑expressing neurons in the hippocampal CA1 region projected from the LS are activated
by social stimuli. As illustrated in Figs. 1 and 2, artificial activation of OXTR+ neurons in the LS improved

preference for social novelty in VPA-treated mice and Nl3:OxtrCre/+ mice. To further investigate the mechanism
underlying this improvement, we attempted to obtain anatomical data to identify the regions projected by the
OXTR+ neurons in the LS and whose neural activities are regulated to control preference for social novelty.
Kawashima et al. described a synthetically enhanced synaptic activity-responsive element (E-SARE) of Arc, one
of the immediate early genes34, which enables selective labelling of neurons that respond to particular stimuli.
We designed a “FLEX” type AAV vector with the E-SARE and tdTomato reporter cDNA. The resultant AAV-ESARE-FLEX-tdTomato was injected into the LS region of Oxtr-Cre mice (Fig. 3A), and the infected mice were
exposed to social stimuli (Social). Analysis of the projections from the OXTR+ neurons in the LS activated by
social stimuli revealed projections to the medial septum (MS), nucleus of the vertical limb of the diagonal band
(VDB), corpus callosum (cc), cingulum (cg), and CA1 region of the hippocampus. Moreover, projections to
the MS, VDB, cc, and cg were observed when the transfected mice were non-socially stimulated (Non-Social);
however, projections from the LS to CA1 were hardly detected in non-socially stimulated mice (Fig. 3B). Fiber
density was calculated by the ratio of total fiber length/volume of the reference region (Fig. 3C)35. The total
length of activated OXTR+ neurons projected from LS to CA1 in social test was significantly larger than in nonsocial test, but this difference was not obtainable in the MS, VDB, and cc, and cg (Fig. 3C). We then confirmed
the co-localization of Gad67 mRNA and OXTR using the Oxtr-Venus mice to examine the OXTR+ neurons in
the LS. The fluorescent signal for > 90% of the OXTR+ neurons in the LS co-localized with that of Gad67 (Fig. 4).
The gene expression levels of Oxtr, Gad65, and Gad67 in the LS of VPA mice and Nl3:OxtrCre/+ mice, assessed
by quantitative real-time PCR, did not change compared with those in control mice (Supplemental Figure S3).
These data signify the importance of the suppressive projections from OXTR+ neurons in the LS to the CA1
in mediating preference for social novelty.

Discussion

In the present study, we analysed the neuropharmacological mechanism in a neurons-subtype and nuclei specific
manners, underlying the amelioration of autism symptoms following OXT administration using the “signal
enhancement strategy”. This strategy was chosen on the basis that the physiological effects of OXT in the brain
are principally generated by the binding of OXT to particular neurons expressing OXTR, and on the presumption
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◂Figure 1.  Activation of oxytocin receptor-expressing neurons in the lateral septum (LS) ameliorated the

abnormal social novelty observed in mice exposed to valproic acid (VPA) and elicited an anxiolytic effect. (A)
Schematic diagram of the protocol (left). Confocal images of the LS (immunostained with c-Fos and Venus) in
Oxtr-Venus mice that received social or non-social stimulation (middle). Number of c-Fos and Venus positive
cells and the number of c-Fos (+) and Venus (+) neurons after social novelty test (N = 3) and non-social state
in the LS (N = 3). Scale bars indicate 100 µm. (B) Mouse communicative function was assessed by recording
neonatal ultrasonic vocalizations. Control: N = 10, VPA: N = 23. Control were Oxtr-Cre mice treated with saline
at E12.5. VPA were Oxtr-Cre mice treated with VPA at E12.5. (C) AAV vector constructs to express designer
receptors exclusively activated by designer drugs (DREADD) (hM3Dq) (top) and a stereotaxic map displaying
the location of hM3Dq expression (down). Adapted from Paxinos and Watson “The Mouse Brain in Stereotaxic
Coodinate” 69. (D) hM3Dq was expressed specifically in the LS (including Bregma + 0.26) of Oxtr-Cre mice and
activated by clozapine N-oxide (CNO). Scale bars indicate 100 µm. (E) Schematic diagram of the protocol for
the behavioral test administered to VPA mice. (F) Investigation time quantified during the social novelty test
(third stage). Control (Ctrl) + saline, Ctrl + CNO, VPA + CNO: N = 8 per group; VPA + saline: N = 11. (G) The
saline- and CNO-treated Ctrl and VPA mice exhibited similar levels of locomotor activity in terms of the total
distance traveled as measured by open field test. N = 8 per group. (H) Number of center entries quantified by the
open field test for the saline- or CNO-treated Ctrl and VPA mice. N = 8 per group. (I) Number of marbles buried
by the saline- and CNO-treated Ctrl and VPA mice. N = 9 per group. Unpaired t-tests were performed for (A,B).
Tukey’s test and Dunn’s multiple comparison test were performed for (G) and (H,I). Paired t-test was performed
for (F). Data are expressed as the mean ± standard error of the mean. *,**p < 0.05, 0.01. All the test mice using
(F–H), and (I) were infected with hM3Dq vector earlier than 2 weeks.
that OXTR is a physiologically major or unique receptor for OXT in brain, and used a Gq/11 type DREADD
signal, similar to OXTR, generated in the OXTR+ neurons of specific brain regions. We selected the LS as the
target region in mouse models with ASD because previous studies have identified a strong association of this
region with social n
 ovelty22. Few reports have stated that the OXT/OXTR signalling in the LS influences social
behavior in normal rodents, but not in ASD model rodents. In the LS of male rats, OXT release was increased
during retrieval of social memory for male juvenile stimuli, and administration of OXTR-antagonist into the LS
impaired the retrieval of social memory in both male juveniles and female adult r ats36. Local OXT release within
LS of male rats occurred in response to social stimuli or exposure to emotional stress such as social defeat37,38. On
the other hand, the experience of social fear conditioning blocks OXT release within the LS during extinction39.
Moreover, administration of OXT or enhancement of OXTR expression in the GABAergic neurons in the LS of
virgin mice attenuated their social f ear40.
We have already reported that LS-region specific deletion of Oxtr gene, using Oxtrfx/fx mice combined with
injection of AAV-Cre, impaired social novelty, as evaluated with the three-chamber t est22. The administration
of arginine vasopressin, a type of neuro-hypophysial hormone closely related to oxytocin, to the LS of rat brain
rescued impaired social m
 emory41.
There are multiple reports about the behavioral function and expressed molecules in LS of Prairie Vole
(Microtus ochrogaster). In the LS of Prairie Vole, there is condensed localization of OXTR and its closely related
family member molecule, the vasopressin receptor 1a, which has a critical role in pair bonding behavior42,43 and
other social/prosocial b
 ehaviors44. The deletion of the Oxtr gene in Prairie Voles caused impaired social novelty
in the three-chamber test45. The combination of pre-and post-wean socially depleted environments in Prairie
Voles reduced social discrimination and socio-spatial memory, and OXTR binding density showed an increase
in LS44. Adult male rats underwent social instability stress in adolescence (SS rats) and impaired social interaction and social recognition. OXTR binding density of the SS rat brain increased in the LS and nACC (nucleus
accumbens shell)46.
Although our study has not proved that the suppression of OXTR expressed in LS was the major cause for
impaired social memory in Oxtr gene knockout (KO) prairie vole, we suspected that the lack of oxytocin/oxytocin
receptor signal in LS might be critical factor to cause impairment in their social novelty.
As a result of the signal enhancement strategy, using artificial expression and activation of hM3Dq molecule
in OXTR+ neurons in the LS, we found that the LS could be a target for improvement of ASD symptoms by
administration of OXT in at least two mouse models of ASD. In this study, we selected LS as the target region.
However, studies have identified several brain regions associated with ASD. One of them is the amygdala, a wellknown brain region with critical functions in emotion, fear, and memory; brain imaging revealed an increased
volume of amygdala in patients with ASD compared healthy controls47,48. Therefore, we deduced that enhanced
signalling via the OXTR+ neurons in the amygdala in addition to the LS contributed to the amelioration of ASD
symptoms. Additionally, we have obtained similar data, which shows that enhanced signalling in the OXTR+
neurons of the medial amygdala ameliorated ASD symptoms (manuscript in preparation). Though it’s our final
goal to solve the complex neurocircuits for formation of social novelty, which are composed of both the inhibitory neurons, expressing OXTR in lateral septal nucleus, shown in the present work, and the excitatory neurons,
also expressing OXTR, in medial amygdaloid nucleus (data not shown), here we report simply about neurons
expressing OXTR in LS. Figure 4 shows that > 90% of the OXTR+ neurons in the LS were GABAergic neurons.
Based on these findings, we conclude that the inhibitory signals in the LS induced by the “signal enhancement,”
which when used in combination, contributed to improve social novelty in VPA mice and Nl3:OxtrCre/+mice.
As illustrated in Figs. 1 and 2, activation of OXTR+ neurons in the LS recovered the preference for social
novelty in two mouse models of ASD that were generated to respond to an environmental cue (VPA mice) or
a genetic mutation of Nl3R451C mice which is one of the representative ASD model with a genetical cue. Previous studies that used VPA-induced animal models of ASD have reported decreased activity of the GABAergic
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Figure 2.  Activation of oxytocin receptor-expressing neurons in the lateral septum ameliorated the abnormal
social novelty in Nl3R451C: Oxtrcre/+ mice. (A) Investigation time quantified during the social novelty by threechamber test (third stage) of Oxtr-Cre (Ctrl) and Nl3R451C: Oxtrcre/+ mice (Nl3:Oxtrcre/+). N = 9 per group. (B)
Total distance traveled as measured with open field test. Ctrl: N = 5, Nl3:Oxtrcre/+: N = 10. (C) Number of
buried marbles quantified repetitive behavior with the marble burying test. Ctrl: N = 10, Nl3:Oxtrcre/+: N = 8.
(D) Schematic diagram of the protocol for virus infection and the single field test in Nl3:Oxtrcre/+ mice. (E)
Behavioral schematic of the single field test. (F) Investigation time during the social novelty (third stage) by
single field test, administered saline to Ctrl (N = 10), CNO to Ctrl (N = 15), saline to Nl3:Oxtrcre/+ (N = 10) and
CNO to Nl3:Oxtrcre/+ (N = 10). All mice using the single field test were infected with hM3Dq vector earlier than
2 weeks. Paired t-tests were performed for three-chamber test and single field test (A,F) and Mann–Whitney
tests were performed for open field test and marble burying test (B,C). *,**p < 0.05, 0.01.
interneurons49 and increased activity of the glutamatergic neurons and glutamate r eceptor50–52; these results
suggest an excitatory/inhibitory imbalance in the neural circuit with an excitation-dominant condition in VPAinduced animal models. Activated OXTR+ neurons via DREADD system in LS of Nl3:OxtrCre/+ resulted in the
improvement of preference for social novelty as observed with the single field test, but not with the three-chamber
test. We consider the possibility that Nl3:OxtrCre/+ mice have additional impairment in behavior, other than their
abnormality in social novelty. This impairment is suspected to be highly sensitive to the complicated structure
with larger size of the three-chamber arena, which has three rooms divided each other, compared with the apparatus for single field test. For example, there is a difference with respect to the ease of detection of an olfactory
stimulus. All neuronal cells in the olfactory bulb express N
 l353, and Nl3 KO mice show olfactory d
 eficiency12.
As there are two walls in the apparatus for three-chamber and the size of the apparatus for the test is larger than
for single field, the spreading of the smell of the stimulant may be different for both tests. We did not detect any
repetitive behavior in VPA mice (Fig. 1I). It has been reported that VPA-treated C57BL/6 mice demonstrated
repetitive behavior, which was evaluated with the Marble bury t est32. On the other hand, Oxtr-Cre mice line,
which was used in the present study after treatment with VPA in utero, has 129× C57BL/6J mixed genetic background. This difference in the genetic background may be responsible for inability to detect repetitive behavior
of VPA-treated ASD model mice.
We showed the OXTR+ neurons, activated by social stimulation in the LS, may project to the CA1 region of
the hippocampus (Fig. 3). Various reports have described the function of the hippocampus in the formation of
social memory33,54,55. The hippocampus is composed of several sub-regions and is essential for social memory.
In the neural circuit of social memory, information proceeds from the entorhinal cortex to the dentate gyrus,
CA3, and then to CA1, which is the main hippocampal output region55–57. The CA2 region is also an important
hub for the formation of social m
 emory55. The hippocampus is composed of several subregions and is essential
for social memory. As most of the OXTR+ neurons in the LS are GABAergic (Fig. 4), we suspected that a portion
of those neurons projecting to the CA1 likely modulate social novelty by altering the E/I balance in the CA1,
such as through inhibition of interneurons and resultant disinhibition of principal neurons in the C
 A158. This
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Figure 3.  Oxytocin receptor (OXTR)-expressing neurons in the lateral septum (LS), which were activated by
social stimulation, projected to the CA1 region of the hippocampus. (A) AAV vector constructs expressing
E-SARE-FLEX-tdTomato (left) and a stereotaxic map displaying the location of vector expression (right). Brain
illustration is an adaption as well as Fig. 1C. (B) Projection site of the OXTR+ neurons in the LS that were
activated by social or non-social stimulation. (C) Quantitative analysis of the density of social stimuli-activated
axon projection was performed as indicated in the “Methods”. Scale bars indicate 100 µm. (Control, no viral
infection and stimulation; MS medial septum, VDB nucleus of the vertical limb of the diagonal band, cc corpus
callosum, cg cingulum) AAV-E-SARE-FLEX-tdTomato was used for the green color in pseudo coloring. N = 3
(Social), N = 6 (Non-social).
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Figure 4.  Oxytocin receptor (OXTR)-expressing neurons in the lateral septum (LS) were GABAergic neurons.
Confocal images of the LS show neurons expressing mRNAs for GAD67 and OXTR in Oxtr-Venus mice (left).
The ratio of the number of OXTR+ neurons of GABA (+) cells and GABA (−) cells in the LS is shown(N = 3)
(right). Unpaired t-tests were performed for the graph. ** p < 0.01. The brain illustration is an adaption as well as
Figs. 1C and 3A.
would lead to the activation of N-methyl-d-aspartate (NMDA) receptor-mediated functions in the hippocampus,
including establishing social memory. On the other hand, suppressed expression of GAD65 or GAD67 (which
are the GABA-synthetic enzymes) were observed in multiple regions including the hippocampus59 in the brains
of VPA mice. We suspected that these suppressed activities of GABAergic neurons might subsequently cause
abnormal social novelty due to impaired signal transmission in the hippocampus. In our study, with application of
DREADDs to the LS of VPA mice, we induced artificial activation of OXTR+ neurons to further suppress basket
cells in the hippocampus which might be one of the projected targets of OXTR+ neurons from the LS (Fig. 4).
We speculated that the resultant disinhibition of principal neurons in CA1 might increase the output signal
required for social memory, leading to amelioration of social novelty. On the other hand, the PV basket cells
in hippocampal CA1 region of Nl3R451C mice formed disrupted tonic endocannabinoid signaling, with notable
reduction of IPSC60, while cholecystokinin basket cells suffered only a slight impairment of IPSC in the similar
condition. Our finding that the artificial activation of septohippocampal projections from OXTR+ GABAergic
neurons in LS in the Nl3R451C mouse brain using DREADDs system, might cause a compensatory effect on
impaired function of CA1 basket cells. This may lead to normal disinhibition of pyramidal neurons in CA1,
followed by establishment of normal social memory. As we have not yet identified the subtype of basket cells, to
which social novelty related OXTR+ septohippocampal neurons project, the detailed mechanism that explains
this hypothesis should be explored in further experiments including anatomical and electrophysiological studies.
We indicated the suppressive function of activation of OXTR+ neurons in the LS on anxiety behavior
(Fig. 1H). This result shows the anxiolytic potential of activation of OXTR+ neurons in the LS. Several studies
have reported the anxiolytic effect of OXT in mice LS. OXT/OXTR signalling in the LS region enhanced fear
memory after treatment with social defeat demonstrated the conditional gene knockout of Oxtr in the LS by
injection of AAV-Cre to the LS of Oxtrfx/fx mice61,62. In contrast, when these mice had social buffering treatment,
the OXT/OXTR signal had an enhancing effect on reducing fear memory. The lactating mice showed activation
of OXT system in the LS and did not express social fear and inhibition of OXT signalling in the LS of Lactating
mice reinstated social fear40.
It has been reported that activation of LS-projecting ventral hippocampal neurons caused subsequent suppression of anxiety b
 ehavior63. Because most projecting neurons in the hippocampus are glutamatergic, we assumed
that anxiety might be suppressed via the activation of inhibitory neurons, including the OXTR+ neurons in the
LS.
Although we could not show the signals induced by OXTR to be totally identical to those induced by hM3Dq,
we detected that the major signalling pathways of OXTR are similar to those of hM3Dq. Herein, we demonstrate
that OXTR+ neurons in the LS are important targets of OXT. Additionally, our findings suggest that the same
region might function as the target of OXT in similar related disorders. It is not known whether OXT is applicable
to all types of patients with ASD. With the acceleration in the application of this analytical approach to multiple
mouse models of ASD with various cues, we will potentially obtain further insight to expand “OXT treatment”
therapy as a more efficient and effective strategy to treat many patients with ASD.

Methods

Animals. Oxtr-Venus mice, Oxtr-Cre mice, and Nl3R451C mice were generated as previously d escribed10,29,64.
Genetic background of Oxtr-Cre were 129× C57BL/6J29 and Nl3R451C were Sv129/C57Bl610. On embryonic day
(E12.5), pregnant Oxtr-Cre mice received a single i.p. injection of 600 mg/kg VPA (Tokyo Chemical Industry
co) dissolved in saline (VPA mice) or only saline (control mice). After weaning at 21 days of age, the mice
were allowed ad libitum access to standard chow and water, and kept at 25 °C in a room with a 12 h light/dark
cycle. All of the animal protocols and procedures for experiments were approved by the Animal Committee of
the Graduate School of Agricultural Science, Tohoku University Ethics Committee, or by Animal Experiments
Committee of Fukushima Medical University. All experiments were conducted according to the ethical and
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safety guidelines of Tohoku University or under the ethical and safety guidelines and regulations of Fukushima
Medical University.

Viral injection. We constructed AAV-E-SARE-FLEX-tdTomato to insert FLEX-eSARE-tdTomato fragment

at BamHI and EcoRI site in AAV-MCS (Addgene). The recombinant vectors were packaged by the viral vector
core at Jichi Medical University. The viral vector, AAV-hSyn-FLEX-hM3Dq-mCherry (Addgene), was injected
bilaterally into the LS (Bregma+ 0.26 mm, lateral+ 0.5 mm, deep+ 2.75 mm) and the viral vector, AAV-E-SAREFLEX-tdTomato34, was injected into one side of the LS on 2 weeks before three-chamber test. The injection
volume was 1.0 µl per side.

Drugs. The animals were injected intraperitoneally with 300 μg/kg CNO (Sigma-Aldrich) 30 min before each
behavioral test.

Ultrasonic vocalization analysis (USV test).

Pups were isolated from their mother on P5 to induce
ultrasonic vocalizations. Each pup was placed in a sound-proof chamber (Metris smart chamber, Metris), and
ultrasonic vocalizations were recorded for 5 min. The vocalizations were analyzed using Sonotrack (Metris). Any
frequency from 25 to 100 kHz was counted as a pup vocalization.

Behavioral tests. All behavioral experiments were conducted during the light phase (9 a.m. to 7 p.m.)
for male mice aged 10–16 weeks. Animals were habituated to the testing room for at least 1 day before any
experiment. For behavior test using DREADD system, littermates were separated into two groups at random.
Littermates belonging to one group were administered with saline and the other with CNO 30 min before the
behavior test.
Three‑chamber test.

The test was performed as previously described in literature65. In brief, to assess
sociability and social novelty, we used a three-compartment social behavior chamber. The chamber was a polyvinyl chloride box (63 cm long × 41 cm wide × 30 cm tall) divided into three compartments with walls made
from clear Plexiglas, with small rectangular openings (5 cm wide × 3 cm tall) allowing access into each chamber.
A wire cage (10 cm bottom diameter, 18 cm tall, vertical bars 1 cm apart) was placed in each side compartment.
The wire cage allowed for auditory, visual, olfactory interactions, and nose contact between the wire bars, but
prevented fighting, between experimental and stimulus mice. The test consisted of 3 × 10 min sessions. The first
session was habituation, in which no stimuli were present. After habituation, the second session was sociability, in which a stimulus mouse (familiar mouse) and an empty cage were present in separate chambers. Adult
DBA/2J male mice were selected to be stimulus mice due to their relatively mild c haracteristics65. The last session measured preference for social novelty, in which the novel DBA/2J mouse (unfamiliar mouse) was placed
inside the remaining (empty) cage. The test mouse thus had a choice between the familiar mouse and the novel
mouse. DBA/2J mice were two to four months old. Each mouse was purchased from a different breeder; one is
from CLEA Japan (Tokyo, Japan) and the other is from Japan SLC (Fukuoka, Japan). The amount of time spent in
each contact zone, defined as the area within 5 cm from the wire cage, was recorded by a video camera fitted on
top of the box. Data acquisition and analysis were performed automatically with the use of ANY-maze behavior
tracking software (Stoelting).

Marble burying test.

The marble burying test was performed as previously described66. Briefly, before the
tests, the mice were acclimated to the test cage (28 × 19 × 30 cm) laid with clean wood chips to a depth of 5 cm
and illuminated at 500 lux. The mice were then placed in the test cage containing 20 equidistantly arranged blue
marbles (14 mm in diameter). We counted the number of marbles obscured by at least two-thirds of the surface
20 min after placing the mice in the test box.

Open field test.

The open field test was performed as previously d
 escribed67. Each mouse was placed in the
center of an open arena (41 × 41 × 35 cm) illuminated at 500 lux and allowed to explore freely for 10 min. During the tests, their position was continually monitored using ANY-maze software (Stoelting). The total distance
travelled and the number of entries to the central area (20 × 20 cm) were assessed.

Single field test.

The single field test was performed as previously r eported68, in a 41 × 41 × 35 cm white
plastic box illuminated at 10 lux. A wire cage (10 cm bottom diameter, 18 cm tall, vertical bars 1 cm apart) was
placed symmetrically (Fig. 2E). The contact zone was defined to be around 5 cm from the wire cage. The test
consisted of the three 10 min sessions. During all the sessions, the test mice could move freely in the box. After
each session, mice were taken out of the box. Immediately after the next stimulants had settled down, the test
mice were returned to the test arena, and the next session was started. The first session was habituation: the subject mouse was placed in an open arena with two round wire cages, as described above, on opposing corners of
the arena. The second session was sociability: an unfamiliar male mouse (stranger 1) that had never been in contact with the subject mouse was placed in one wire cage while the other wire cage was empty. The third session
measured preference for social novelty: another unfamiliar male mouse (stranger 2) was placed in the previously
empty wire cage. The test mouse could move within the arena freely in each session. The amount of time spent in
each contact zone was recorded using a video camera fitted on top of the box, and data acquisition and analysis
were performed automatically with the use of ANY-maze software (Stoelting).
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Stimulation. Our “social stimuli” refers to undergoing the social novelty stage (third stage of the threechamber test) and “non-social stimuli” refers to undergoing the habituation stage (first stage of the three-chamber test). And then, 90 min after the stimulation, the test mice were perfused as follows.
Immunohistochemistry and image acquisition. The mice were transcardially perfused with saline

followed by 4% paraformaldehyde. After perfusion, the brains were extracted and post-fixed in 4% paraformaldehyde for 1 day. The brains were sectioned coronally (50 μm sections) using a vibratome (Leica) and collected
in phosphate-buffered saline (PBS). The sections were permeabilized using 0.3% triton/PBS (PBST) for 30 min
and then blocked with 1% blocking reagent in maleic acid buffer (Roche) for 30 min. After blocking, the sections were incubated overnight in rabbit polyclonal anti-cFos antibody (1:1000; RPCA-cFos; EnCor) or chicken
polyclonal anti-GFP antibody (1:1000; ab13970; Abcam). After incubation with the primary antibody, the sections were washed three times with PBS and incubated with Alexa 594-conjugated donkey anti-rabbit (1:1000;
A21207; Life technologies) or Alexa 488-conjugated goat anti-chicken (1:1000; A11039; Life technologies) secondary antibodies and DAPI for 2 h. After incubation with the secondary antibody, the sections were washed
two times with PBS. The confocal images were acquired with an LSM780 or 800 (Zeiss) using 10 × or 20 × objective lenses. Three brain slices from each mouse were collected from the bregma (+ 0.4 to + 0.25).

Analysis of tractus neural projection. Post-fixation, the brains were sectioned coronally (50 μm sections) using a vibratome (Leica) and collected in PBS. The confocal images were acquired with an LSM780 or
800 (Zeiss) using 10 × objective lenses. The fibrous fluorescent signal was defined as activating neuronal cells
projected from the LS area. To examine the total length of signal, three sections from all individual mice were
analysed. Signal length was measured using ImageJ freeware (National Institute of Health, Bethesda, MD). The
relative value indicating the density of axon projection was calculated as follows: total axon length detected
by fluorescence in a constant-volume brain cube (50 µm × 870 µm × 650 µm) section from each nucleus in the
stimulus condition and those with no stimuli as control were measured, and these data were divided by cube
volume and s hown35.
In situ hybridization (ISH). The brains were sectioned coronally (30 μm sections) using a cryostat (Leica).
ISH was carried out at room temperature unless otherwise indicated. Brain sections were incubated 10 min in
4% PFA/PB and then washed 3 × 5 min in DEPC-PBS. They were placed in Detergent mix (1% Nonidet P-40,
1% SDS, 0.5% Deoxycholate, 50 mM Tris–HCl (pH 8.0), 1 mM EDTA (pH 8.0), 150 mM NaCl, DEPC-H2O)
for 2 × 30 min. and then washed 10 min in DEPC-PBS. They were hybridized by incubating in hybridization
buffer containing probes for GAD67 (DIG-labeled) (1.0 µg/mL) at 70 °C overnight. Post-hybridization washes
were performed sequentially 3 × 45 min at 70 °C in Solution X (2 × SSC, 50% Formamide, 1% SDS, DEPC-H2O),
3 × 15 min in wash buffer containing 0.1% Tween-20 in TBS. They were incubated for 1 h in blocking buffer
(10% normal sheep serum in TBST). After blocking, they were incubated for 2 h in anti-digoxygen-AP (roche),
washed 3 × 15 min in TBST and then incubated 10 min in 0.1 M Tris (pH 8.2). They were incubated 3–4 h in Fast
red (roche) and then washed 3 × 10 min in PBS. After washing they were conducted immunohistochemistry as
detailed above. Rabbit polyclonal anti-GFP antibody (1:1000; 598; MBL) and Alexa 488-conjugated goat antirabbit (1:1000; A11034; Life technologies) were used as primary and secondary antibodies, respectively. Three
brain slices from each mouse were collected from Bregma + 0.4 to + 0.25.
Quantification‑real time PCR.

Total RNA was extracted from the LS of the test mice by homogenization in RNAiso (Takara #9108, Japan) according to the manufacturer’s instructions. RNA (1 µg) was reversetranscribed to cDNA using a PrimeScript RT reagent kit with a genomic DNA eraser (Takara #RR047A, Japan)
following the manufacturer’s instructions. cDNA concentration was measured using a NanoDrop™ 1000 spectrophotometer (Thermo Fisher Scientific, USA). SYBR Premix Ex Taq II (Takara #RR420A, Japan), and the
Thermal Cycler Dice Real Time System (Takara #TP900, Japan) was used for quantitative real-time PCR (qRTPCR) to detect gene expression. The primers used for target detection were 5′-GCGGGAGCGGATCCTAATA-3′
and 5′-TGGTGCATCCATGGGCTAC-3′ for Gad1gene expression, 5′-TCGGAAACACAAGTGGAAGC-3′ and
5′-GACCAGGAGAGCCGAACATT-3′ for Gad2 gene expression, 5′-GGAAGTCCAGTGGGATGAGA-3′ and
5′-TCCAGCTCCAAATGCTTTCT-3′ for Oxtr gene expression, and 5′-TGACGTGCCGCCTGGAGAAA-3′
and 5′-AGTGTAGCCCAAGATGCCCTTCAG-3′ for Gapdh gene expression.

Statistics. Statistical analysis was performed using GraphPad Prism 6 for Windows (GraphPad Software).
Statistical comparisons of open field test, self-grooming test and marble burying test for the VPA mice and control mice were performed using one-way ANOVA followed by Tukey’s test or Dunn’s multiple comparison test,
and paired t-test was used to compare three-chamber test and single field test. For Nl3R451C mice and the controls,
statistical comparisons of open field test and marble burying test were performed with Mann–Whitney test, and
paired t-test was used to compare three-chamber test and single field test. Statistical analysis of the number of
stained cells, USV calls, and rate of OXTR+ cells were performed with unpaired t-test. The results were considered statistically significant at p < 0.05.
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